Notably, in AML, KLRB1high CD8+ TRM exhibited elevated expression of multiple exhaustion‐related markers such as TOX, LAG3, TIGIT, and CD160, except PDCD1, whose expression pattern was opposite from that of KLRB1 (Figure 7D). The gene discussed is CD160; the disease is acute myeloid leukemia.